Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-22 Sale |
2022-08-24 8:17 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
10,186 | $6.23 | $63,459 | 0 (Indirect Direct) |
View |
| 2021-11-29 Sale |
2021-12-01 7:07 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
441,290 | $3.9297 | $1,734,150 | 9,607,934 (Indirect) |
View |
| 2021-11-17 Sale |
2021-11-19 4:38 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner |
2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) |
View |
| 2021-05-27 Purchase |
2021-06-01 6:42 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
245,020 | $4.4719 | $1,095,693 | 10,049,224 (Indirect) |
View |
| 2021-05-24 Purchase |
2021-05-26 4:56 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
398,714 | $3.9571 | $1,577,731 | 9,804,204 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-22 Equity Swap |
2022-08-24 8:19 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
3,519 | $0 | 0 (Indirect) |
View |
| 2022-08-22 Equity Swap |
2022-08-24 8:17 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
9,607,934 | $6.23 | 0 (Indirect) |
View |
| 2022-08-22 Equity Swap |
2022-08-24 4:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
3,519 | $0 | 0 (Indirect) |
View |
| 2022-08-22 Equity Swap |
2022-08-24 4:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
9,607,934 | $6.23 | 0 (Indirect) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:51 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
236 | $2.7115 | 9,618,356 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:51 pm |
N/A 2032-06-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
236 | $0 | 9,618,356 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
236 | $2.72 | 9,618,120 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:05 pm |
N/A 2032-06-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
236 | $0 | 9,618,120 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
189 | $3.4085 | 9,617,837 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 5:05 pm |
N/A 2032-05-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
189 | $0 | 9,617,837 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-17 5:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
188 | $3.4085 | 9,617,647 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-17 5:07 pm |
N/A 2032-05-13 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
188 | $0 | 9,617,647 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-03 5:00 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
185 | $3.468 | 9,617,456 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-03 5:00 pm |
N/A 2032-04-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
185 | $0 | 9,617,456 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-18 6:31 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $3.7145 | 9,617,259 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-18 6:31 pm |
N/A 2032-04-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $0 | 9,617,259 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:38 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
177 | $3.6295 | 9,617,090 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:38 pm |
N/A 2032-03-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
177 | $0 | 9,617,090 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:04 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
190 | $3.366 | 9,616,926 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:04 pm |
N/A 2032-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
190 | $0 | 9,616,926 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
185 | $3.4765 | 9,616,731 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:07 pm |
N/A 2032-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
185 | $0 | 9,616,731 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $3.791 | 9,616,530 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:05 pm |
N/A 2032-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $0 | 9,616,530 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:19 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,675 | $3.9355 | 9,617,867 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:19 pm |
N/A 2032-01-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,675 | $0 | 9,617,867 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 8:26 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
148 | $4.182 | 9,614,665 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 8:26 pm |
N/A 2032-01-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
148 | $0 | 9,614,665 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-14 6:27 pm |
N/A 2032-01-12 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
78,552 | $0 | 78,552 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
157 | $3.9185 | 9,614,526 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 5:05 pm |
N/A 2031-12-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
157 | $0 | 9,614,526 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:58 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $3.5785 | 9,614,385 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:58 pm |
N/A 2031-12-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $0 | 9,614,385 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
186 | $3.315 | 10,055,515 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:05 pm |
N/A 2031-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
186 | $0 | 10,055,515 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
181 | $3.4085 | 10,055,324 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 5:05 pm |
N/A 2031-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
181 | $0 | 10,055,324 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 5:05 pm |
N/A 2031-10-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
181 | $0 | 10,055,143 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
181 | $3.417 | 10,055,143 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-19 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
183 | $3.366 | 10,054,964 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-19 5:05 pm |
N/A 2031-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
183 | $0 | 10,054,964 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
182 | $3.3915 | 10,054,780 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 5:05 pm |
N/A 2031-09-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
182 | $0 | 10,054,780 (Direct) |
View |
| 2021-09-15 Option Award |
2021-09-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
546 | $3.3915 | 10,054,962 (Direct) |
View |
| 2021-09-15 Option Award |
2021-09-17 5:05 pm |
N/A 2031-09-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
546 | $0 | 10,054,962 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-03 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
201 | $3.0685 | 10,054,071 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-03 5:05 pm |
N/A 2031-07-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
201 | $0 | 10,054,071 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-19 6:57 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
193 | $3.196 | 10,053,862 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-19 6:57 pm |
N/A 2031-07-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
193 | $0 | 10,053,862 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 8:35 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
170 | $3.638 | 10,053,646 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 8:35 pm |
N/A 2031-06-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
170 | $0 | 10,053,646 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:34 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
148 | $4.165 | 10,053,454 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:34 pm |
N/A 2031-06-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
148 | $0 | 10,053,454 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 5:03 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $3.655 | 10,053,327 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 5:03 pm |
N/A 2031-05-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $0 | 10,053,327 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 8:26 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
193 | $3.196 | 9,409,448 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 8:26 pm |
N/A 2031-05-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
193 | $0 | 9,409,448 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 8:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
163 | $3.774 | 9,409,225 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 8:05 pm |
N/A 2031-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
163 | $0 | 9,409,225 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 9:38 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $3.553 | 9,409,498 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 9:38 pm |
N/A 2031-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
173 | $0 | 9,409,498 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 7:35 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
172 | $3.604 | 9,409,324 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 7:35 pm |
N/A 2031-03-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
172 | $0 | 9,409,324 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:43 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
127 | $4.8535 | 9,409,107 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:43 pm |
N/A 2031-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
127 | $0 | 9,409,107 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
37 | $16.22 | 15,517,223 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A 2031-03-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
37 | $0 | 15,517,223 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:36 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
139 | $4.454 | 9,408,992 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:36 pm |
N/A 2031-02-26 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
139 | $0 | 9,408,992 (Direct) |
View |